FINACEA
LEO PHARMA INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of FINACEA in Canada?
Yes. FINACEA 15% has an active shortage reported to Health Canada (last updated October 27, 2026).
Why is FINACEA not available?
The reason the manufacturer reported: Demand increase for the drug.
When will FINACEA be available again?
The manufacturer's estimated resolution date is January 15, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02270811
Strength
15%
Dosage Form
GEL
Route
TOPICAL
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Demand increase for the drug.
Disruption of the manufacture of the drug.
Other Products from LEO PHARMA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
150MG · DIN 02521288
300MG · DIN 02540193
20MG · DIN 02560704
DIN 02319012
DIN 02244126
50MCG · DIN 01976133
50MCG · DIN 02150956
DIN 02457393
DIN 02474883
2% · DIN 00586668
DIN 02238578
2% · DIN 00586676